Key result
Reclassification of renal function stages by the novel Xiangya-s equation compared to the Cockcroft-Gault equation was associated with predicting stroke or systemic embolism.
Why the study?
Previously reported equations to estimate renal function have limited accuracy in CKD patients, and misestimating renal function may increase adverse outcomes associated with inappropriate drug dosing.
Does the Xiangya-s equation provide more accurate GFR estimates and better predict clinical outcomes for DOAC dosing compared to standard equations in Chinese patients with CKD and AF?
Observational (n=4,050)
Yes
Does the Xiangya-s equation provide more accurate GFR estimates and better predict clinical outcomes for DOAC dosing compared to standard equations in Chinese patients with CKD and AF?
The novel Xiangya-s equation provides more accurate GFR estimation in Chinese CKD patients than standard formulas, which may improve the appropriateness of DOAC dosing and reduce adverse clinical outcomes in patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Xiangya-s reclassification may refine stroke risk stratification in Chinese AF patients with CKD; leaves open its utility for DOAC dosing guidance.
Background: Over/under-estimating renal function may increase inappropriate dosing strategy associated adverse outcomes; however, previously reported equations to estimate renal function have limited accuracy in chronic kidney disease (CKD) patients. Consequently, we intended to develop a novel equation to precisely estimate renal function and subsequently guide clinical treatment for CKD patients. Methods: A novel approach, Xiangya-s equation, to estimate renal function for CKD patients was derived by linear regression analysis and validated in 1885 patients with measured glomerular filtration rate (mGFR) < 60 ml/min/1.73 m 2 by renal dynamic imaging at three representative hospitals in China, with the performance evaluated by accuracy, bias and precision. In the meanwhile, 2,165 atrial fibrillation (AF) patients who initiated direct oral anticoagulants (DOACs) between December 2015 and December 2018 were identified and renal function was assessed by estimated creatinine clearance (eCrCl). Events per 100 patient-years was calculated. Cox proportional hazards regression was applied to compare the incidence of outcomes of each group. Results: Xiangya-s equation demonstrated higher accuracy, lower bias and improved precision when compared with 12 creatinine-based and 2 CysC-based reported equations to estimate GFR in multi-ethnic Chinese CKD patients. When we applied Xiangya-s equation to patients with AF and CKD prescribed DOACs, wide variability was discovered in eCrCl calculated by the Cockcroft-Gault (CG), Modification of Diet in Renal Disease Study (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), Xiangya equation which we had developed for generally patients and Xiangya-s equations, which persisted after grouping by different renal function stages. Equation choice affected drug-dosing adjustments, with the formulas agreeing for only 1.19%, 5.52%, 33.22%, 26.32%, and 36.61% of potentially impacted patients for eCrCl cutoffs of <15, <30, 15–49, 30–49, ≥50 ml/min, respectively. Relative to CG equation, accordance in DOACs dosage was 81.08%, 88.54%, 62.25%, and 47.68% for MDRD, CKD-EPI, Xiangya and Xiangya-s equations for patients with CrCl < 50 ml/min (eCrCl cutoffs of <30, 30–49, ≥50 ml/min), respectively. Reclassification of renal function stages by Xiangya-s equation was significantly associated with stroke or systemic embolism, non-major clinically relevant bleeding and any bleeding events. Conclusion: Xiangya-s equation provides more accurate GFR estimates in Chinese CKD patients who need consecutive monitoring of renal function, which may assist clinicians in choosing appropriate drug dosages.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2021) conducted an observational in Chronic Kidney Disease and Atrial Fibrillation (n=4,050). Xiangya-s equation for estimating GFR vs. Cockcroft-Gault (CG) equation was evaluated on Stroke or systemic embolism associated with reclassification of renal function stage by Xiangya-s equation compared to CG equation in patients with eCrCl < 50 ml/min (HR 2.05, 95% CI 1.41-2.95). Reclassification of renal function stages by the novel Xiangya-s equation compared to the Cockcroft-Gault equation was associated with predicting stroke or systemic embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: